Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

被引:0
作者
M. Schmidt-Hieber
J. Bierwirth
D. Buchheidt
O. A. Cornely
M. Hentrich
G. Maschmeyer
E. Schalk
J. J. Vehreschild
Maria J. G. T. Vehreschild
机构
[1] HELIOS Klinikum Berlin-Buch,Clinic for Hematology, Oncology, Tumor Immunology and Palliative Care
[2] BZH GmbH,Deutsches Beratungszentrum für Hygiene
[3] University of Heidelberg,3rd Department of Internal Medicine
[4] University of Cologne, Hematology and Oncology
[5] German Center for Infection Research (DZIF), Mannheim University Hospital
[6] partner site Bonn-Cologne,1st Department of Internal Medicine
[7] University of Cologne,Clinical Trials Centre Cologne, ZKS Köln
[8] Rotkreuzklinikum München,Department III for Internal Medicine, Hematology and Oncology
[9] Ernst-von-Bergmann Klinikum,Department of Hematology, Oncology and Palliative Care
[10] Otto-von-Guericke University,Department of Hematology and Oncology, Medical Center
[11] Hospital of the University of Cologne,1st Department of Internal Medicine
来源
Annals of Hematology | 2018年 / 97卷
关键词
Abdominal complications; Colitis; Diarrhea; Chemotherapy; Cancer; Infection;
D O I
暂无
中图分类号
学科分类号
摘要
Cancer patients frequently suffer from gastrointestinal complications. In this manuscript, we update our 2013 guideline on the diagnosis and management of gastrointestinal complications in adult cancer patients by the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). An expert group was put together by the AGIHO to update the existing guideline. For each sub-topic, a literature search was performed in PubMed, Medline, and Cochrane databases, and strengths of recommendation and the quality of the published evidence for major therapeutic strategies were categorized using the 2015 European Society for Clinical Microbiology and Infectious Diseases (ESCMID) criteria. Final recommendations were approved by the AGIHO plenary conference. Recommendations were made with respect to non-infectious and infectious gastrointestinal complications. Strengths of recommendation and levels of evidence are presented. A multidisciplinary approach to the diagnosis and management of gastrointestinal complications in cancer patients is mandatory. Evidence-based recommendations are provided in this updated guideline.
引用
收藏
页码:31 / 49
页数:18
相关论文
共 1022 条
[91]  
Yothers G(2010)Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA) Infect Control Hosp Epidemiol 31 431-1053
[92]  
Begovic M(2009)Clostridium difficile associated infection, diarrhea and colitis World J Gastroenterol 15 1554-2768
[93]  
Sloan JA(2005)Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Lancet 366 1079-237
[94]  
Goldberg RM(2016)Advanced chronic kidney disease: a strong risk factor for Clostridium difficile infection Korean J Intern Med 31 125-828
[95]  
Sargent DJ(2012)Clostridium difficile infection in patients with chronic kidney disease Mayo Clin Proc 87 1046-554
[96]  
Vargas-Chanes D(2016)Identification of risk factors associated with Clostridium difficile infection in liver transplantation recipients: a single-center analysis Transplant Proc 48 2763-26
[97]  
Nair S(2016)Risk factors for Clostridium difficile diarrhea in patients with solid organ transplantation Prog Transplant 26 231-S18
[98]  
Cha SS(2014)Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis Biol Blood Marrow Transplant 20 823-277
[99]  
Abigerges D(2016)Adverse event reporting for proton pump inhibitor therapy: an overview of systematic reviews Otolaryngol Head Neck Surg 155 547-995
[100]  
Chabot GG(2014)European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection Clin Microbiol Infect 20 1-706